GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline appears in FDA public data with 10 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1245-2014, Class III) was initiated on February 20, 2014.
Summary
- Total Recalls
- 10
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1245-2014 | Class III | Nicorette (nicotine polacrilex) Lozenges Mini, 2 mg, Original Flavor, 20 Lozenge, 27 Lozenge, 81 Loz | February 20, 2014 |
| D-1239-2014 | Class III | Nicotine polacrilex lozenge, 4 mg, Cherry Flavor, 72 count cartons, 81 count cartons, and 108 count | February 20, 2014 |
| D-1243-2014 | Class III | Nicotine polacrilex lozenge, 4 mg, Mint Flavor, 81 Lozenge and 189 Lozenge Vials. OTC. Labeled Nicor | February 20, 2014 |
| D-1240-2014 | Class III | Nicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 coun | February 20, 2014 |
| D-1246-2014 | Class III | Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vial | February 20, 2014 |
| D-1244-2014 | Class III | Nicorette Lozenge, Nicoderm CQ, and Nicorette Gum nicotine polacrilex combination. Contains 30 Pie | February 20, 2014 |
| D-1241-2014 | Class III | Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 coun | February 20, 2014 |
| D-1238-2014 | Class III | Nicotine polacrilex lozenge, 2 mg, Cherry Flavor, 72 count vials, 81 count vials, and 108 count vial | February 20, 2014 |
| D-1247-2014 | Class III | Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 3 | February 20, 2014 |
| D-1242-2014 | Class III | Nicotine polacrilex lozenge, 2 mg, Mint Flavor, 81 count cartons and 189 count cartons. OTC. Labeled | February 20, 2014 |